IND Swift Laboratories

IND Swift Laboratories EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of IND Swift Laboratories (INDSWFTLAB.NS) as of Oct 16, 2026 is -6.72. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was -8.16 — a change of -17.66% (higher).

EV/FCF

-6.72

YoY

-17.66%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of IND Swift Laboratories is 2026 -6.72 . EV/FCF (Enterprise Value to Free Cash Flow) of IND Swift Laboratories was 2025 -8.16 . It decreases by -17.66% higher compared to the previous year.

The IND Swift Laboratories EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2019
-28.79 INR
Jan 1, 2020
19.14 INR
Jan 1, 2021
16.60 INR
Jan 1, 2022
15.88 INR
Jan 1, 2023
11.07 INR
Jan 1, 2024
-3.36 INR
Jan 1, 2025
-8.16 INR
Jan 1, 2026
-6.72 INR
The IND Swift Laboratories EV/FCF history
YEAREV/FCFYoY
-6.72-17.66%
-8.16+143.08%
-3.36-130.32%
11.07-30.28%
15.88-4.38%
16.60-13.25%
19.14-166.48%
-28.79-166.52%
43.29+14.43%
37.83-30.87%
54.72+25.75%
43.51-40.04%
72.57—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

IND Swift Laboratories Stock analysis

What does IND Swift Laboratories do? IND Swift Laboratories Ltd is a pharmaceutical company based in Chandigarh, India, operating within the healthcare sector. The company specializes in the manufacturing, development, and marketing of pharmaceutical ingredients, including intermediates and formulations. It employs 1,496 full-time employees and went public via an IPO on March 15, 2002. IND Swift Laboratories serves as an API (Active Pharmaceutical Ingredient) partner for various organizations in both generic and innovative pharmaceutical domains. The company provides reference standards and impurities for multiple active pharmaceutical ingredients (APIs), adhering to standards such as the British Pharmacopoeia (BP) and European Pharmacopoeia (EP). Its product portfolio includes over 25 APIs, with all impurities supplied alongside comprehensive documentation, including Certificates of Analysis and Material Safety Data Sheets (MSDS). The firm maintains a research center spanning 40,000 square feet, dedicated to developing process technology for APIs across various therapeutic categories. The company's website is www.indswiftlabs.com, and it operates under the ticker symbol INDSWFTLAB.NS with ISIN INE915B01019. IND Swift Laboratories focuses on supplying high-quality pharmaceutical components to support global pharmaceutical manufacturing needs. IND Swift Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about IND Swift Laboratories stock

EV/FCF (Enterprise Value to Free Cash Flow) of IND Swift Laboratories is -6.72 in 2026.

EV/FCF (Enterprise Value to Free Cash Flow) of IND Swift Laboratories changed from -8.16 to -6.72, representing a -17.66% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) IND Swift Laboratories since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s IND Swift Laboratories with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — IND Swift Laboratories

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — IND Swift Laboratories